Mark Lanasa, M.D., Ph.D., joined the company in February 2022 as Senior Vice President, Chief Medical Officer for Solid Tumors. Prior to joining BeiGene, Dr. Lanasa served as Vice President and Global Clinical Head, Late Development Oncology at AstraZeneca from 2019 to 2022. He previously...
Read More →